Organics Corporation of America DBA Ambix Laboratories

FDA Regulatory Profile

Organics Corporation of America DBA Ambix Laboratories appears in FDA public data with 1 recall, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0559-2022, Class II) was initiated on December 6, 2021.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0559-2022Class IINaturesPlus Advanced Therapeutics Glucosamine Chondroitin MSM Ultra Rx- Joint Cream, 4 oz tubes, ManDecember 6, 2021